Optimizing epoetin therapy in end-stage renal disease: the case for subcutaneous administration.

Besarab, A

Optimizing epoetin therapy in end-stage renal disease: the case for subcutaneous administration. [electronic resource] - American journal of kidney diseases : the official journal of the National Kidney Foundation Aug 1993 - 13-22 p. digital

Publication Type: Journal Article; Review

0272-6386

10.1016/0272-6386(93)70177-z doi


Anemia--drug therapy
Erythropoietin--administration & dosage
Hematocrit
Humans
Injections, Subcutaneous
Kidney Failure, Chronic--complications
Recombinant Proteins--administration & dosage